Manufacturing Challenges And Strategies For Autologous Gene Modified Cell Therapies
Time: 3:30 pm
day: Day Two
Details:
- This presentation will aim to outline the challenges of commercial manufacture and release of Autologous Gene Therapies
- The presentation will explain how solutions such as use of high throughput analytics will complicate the logistics whilst also increasing the cost of goods
- The risks involved in the solution of technically upskilling the commercial workforce by means of apprenticeship schemes will also be challenged
- Strategies of introducing mature solutions from sectors outside of Pharmaceuticals and Life Sciences will be discussed
